Trial Profile
Carfilzomib for Treatment of Chronic Graft vs. Host Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Apr 2022
Price :
$35
*
At a glance
- Drugs Carfilzomib (Primary)
- Indications Graft-versus-host disease
- Focus Adverse reactions; Therapeutic Use
- 27 Sep 2018 Status changed from active, no longer recruiting to completed.
- 05 Dec 2017 Planned primary completion date changed from 1 Jun 2018 to 12 Jun 2018.
- 05 Dec 2017 Status changed from recruiting to active, no longer recruiting.